Antibiotic resistance and molecular characterization of non-invasive clinical Haemophilus influenzae isolates in Germany 2019 and 2020
Thiemo Frank, Esther Wohlfarth, Heike Claus, Manuel Krone, Thiên-Trí Lâm, Michael Kresken, Study Group ‘Antimicrobial Resistance’ of the Paul Ehrlich Society for Infection Therapy · 2024
Read Antibiotic resistance and molecular characterization of non-invasive clinical Haemophilus influenzae isolates in Germany 2019 and 2020 by Thiemo Frank, Esther Wohlfarth, Heike Claus, Manuel Krone, Thiên-Trí Lâm, Michael Kresken, Study Group ‘Antimicrobial Resistance’ of the Paul Ehrlich Society for Infection Therapy (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11631347.txt.
Description
Thiemo Frank and co-authors track drug resistance in a germ that causes ear, nose, and throat ills in Germany, in a 2024 study. Such ills drive much of the antibiotic use in clinics, so fresh counts of what still works guide sound care.
Labs in a watch network sent in two hundred fifteen samples from 2019 and 2020. The top rates of resistance hit three common drugs, each near one in six or one in seven samples. Gene reads traced most cases to known shields: an enzyme that breaks one drug and tweaks in a target that blunt the next. Two samples held fresh tweaks not yet tied to resistance. The authors set the counts and gene maps as a base for treatment rules.
Catalog record
| CREATOR | Thiemo Frank, Esther Wohlfarth, Heike Claus, Manuel Krone, Thiên-Trí Lâm, Michael Kresken, Study Group ‘Antimicrobial Resistance’ of the Paul Ehrlich Society for Infection Therapy |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |